Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial
Titel:
Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial
Auteur:
Welt, A. Marschner, N. Lerchenmueller, C. Decker, T. Steffens, C.-C. Koehler, A. Depenbusch, R. Busies, S. Hegewisch-Becker, S.